Establishment Labs Holdings INC Form 4 insider transactions

ESTABLISHMENT LABS HOLDINGS INC. CEO Filippo Caldini received awards of 8,185 common shares and options for 14,275 shares, vesting over four years.

Establishment Labs Holdings Director Juan Jose Chacon Quiros acquired 10,285 common shares and 14,906 stock options, increasing his beneficial ownership.

Establishment Labs Holdings Inc. Director Edward J. Schutter acquired 257 common shares at $72.88 each, increasing his direct beneficial ownership to 138,272 shares.

Establishment Labs Holdings Inc. Director Bryan Slotkin acquired 222 common shares valued at $72.88 per share in lieu of a cash retainer.

Establishment Labs Holdings Director Ann Custin acquired 282 common shares at $72.88 each, opting for equity in lieu of cash compensation.

Establishment Labs Holdings Inc. Director Leslie Gillin acquired 231 common shares at $72.88 each as part of a compensation plan.

Establishment Labs Holdings Director Nicholas Sheridan Lewin has filed a Form 4 indicating a future acquisition of 343 common shares on December 31, 2025, as equity compensation.

ESTABLISHMENT LABS HOLDINGS INC. Director Juan Jose Chacon Quiros reported a gift of 50,000 common shares to an entity controlled by his brother.

JW Asset Management and affiliated entities, a 10% owner and director of Establishment Labs Holdings Inc., reported the sale of 11,000 common shares for approximately $737,770 under a Rule 10b5-1 plan.

JW Asset Management and related entities reported the sale of 2,500 common shares of Establishment Labs Holdings Inc. at $65.09 per share, reducing their beneficial ownership to 3,072,694 shares.

JW Asset Management and affiliated entities sold 7,591 shares of Establishment Labs Holdings Inc. common stock for $65 per share.

Establishment Labs Director Edward J. Schutter acquired 457 common shares in lieu of a cash retainer, increasing his direct beneficial ownership to 138,015 shares.

Establishment Labs Holdings Director Bryan Slotkin acquired 396 common shares at $40.99 each, increasing his direct beneficial ownership to 29,748 shares.

Establishment Labs Holdings Director Ann Custin acquired 503 common shares in lieu of a cash retainer, increasing her beneficial ownership to 21,087 shares.

Establishment Labs Holdings Inc. Director Nicholas Sheridan Lewin acquired 609 common shares by electing to receive equity in lieu of a cash retainer.

Leslie Gillin, a Director at Establishment Labs Holdings Inc., received 411 common shares in lieu of a cash retainer payment.

JW Asset Management and related entities, a 10% owner and director of Establishment Labs Holdings Inc., reported the sale of 940 call options.

Establishment Labs Holdings Inc. Director Nicholas Sheridan Lewin acquired 2,600 common shares at $37.85 each, increasing his indirect beneficial ownership.

Establishment Labs Holdings Inc. director Nicholas Sheridan Lewin acquired 2,300 common shares indirectly through his spouse.

Establishment Labs Holdings Inc. CEO Filippo Caldini acquired 2,850 common shares at $35.20 each, increasing his direct beneficial ownership.

Establishment Labs Holdings Inc. CEO Filippo Caldini plans to acquire 2,850 common shares in a future transaction.

Multiple entities associated with JW Asset Management, LLC, including director Jason G. Wild, have reported the sale of 200 call options on Establishment Labs Holdings Inc. common stock.

A group of reporting persons, including JW Asset Management, LLC and director Jason G. Wild, sold call options on Establishment Labs Holdings Inc. stock.

JW Asset Management, a 10% owner and director, along with related entities, reported the sale of 9,700 common shares of Establishment Labs Holdings Inc. at $44.38 per share, effective July 1, 2025.

Establishment Labs Holdings Inc. Director Ann Custin will acquire 510 common shares at $42.71 each on June 30, 2025, as part of her compensation policy.

Leslie Gillin, a Director at Establishment Labs Holdings Inc., acquired 395 common shares valued at $42.71 per share, increasing her direct beneficial ownership to 15,105 shares.

Establishment Labs Holdings Inc. Director Bryan Slotkin acquired 380 common shares at $42.71 each, increasing his beneficial ownership to 29,352 shares, as part of an equity compensation election.

Establishment Labs Holdings Inc. Director Nicholas Sheridan Lewin acquired 585 common shares at $42.71 each, choosing equity in lieu of a quarterly cash retainer.

Director Edward J. Schutter of Establishment Labs Holdings Inc. acquired 439 common shares valued at $42.71 each, increasing his beneficial ownership to 137,558 shares, as part of his director compensation.

Edward J. Schutter, a Director at Establishment Labs Holdings Inc., reported a transfer of 43,089 common shares to EJS Capital Management LLC, disclaiming beneficial ownership of the transferred shares.